代谢综合征与择期腰椎融合术后30天结局
该回顾性队列研究分析2006至2013年ACS-NSQIP数据,纳入择期后路腰椎融合患者,比较合并代谢综合征(MetS)者与无MetS者的30天结局。MetS定义为需药物治疗的高血压、糖尿病及BMI≥30 kg/m²。MetS与肺部并发症、脓毒症和急性术后肾衰竭风险升高独立相关,但仅轻度增加总体并发症,与30天再手术或再入院率升高无关。
要点
- MetS是肺部并发症(OR 1.51)、脓毒症(OR 1.56)和急性术后肾衰竭(OR 6.95)的独立预测因素。
- MetS患者总体并发症仅轻度增加,30天再手术或再入院率未升高。
- MetS患者总住院时间轻度增加(4.38天 vs 3.81天,P<0.001)。
核心结论
- MetS是择期腰椎融合术后急性肾衰竭的预测因素,但仅轻度增加总体并发症风险,且与30天再手术或再入院率升高无关。
研究设计与样本
- 回顾性队列研究,分析2006至2013年ACS-NSQIP数据,纳入择期后路腰椎融合患者,排除急诊手术、感染、肿瘤病例和翻修手术。
主要发现
- MetS患者主要并发症轻度增加(P=0.040),次要并发症轻度增加(P=0.003)。
- MetS患者肺部并发症发生率为1.9% vs 1.0%(P=0.001),脓毒症为1.7% vs 0.9%(P=0.005),急性术后肾衰竭为0.4% vs 0%(P<0.001)。
- 多因素分析显示MetS为肺部并发症(OR 1.51;95%CI 1.00-2.27;P=0.048)、脓毒症(OR 1.56;95%CI 1.01-2.42;P=0.039)和急性术后肾衰竭(OR 6.95;95%CI 2.23-21.67;P=0.001)的独立预测因素。
- MetS患者总住院时间轻度增加(4.38天 vs 3.81天;P<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: A retrospective cohort study. OBJECTIVE: The aim of this study was to evaluate the effect of metabolic syndrome (MetS) on 30-day morbidity and mortality following elective lumbar spinal fusion. SUMMARY OF BACKGROUND DATA: MetS is a variable combination of hypertension, obesity, elevated fasting plasma glucose, and dyslipidemia.MetS has been associated with an increased risk of postoperative morbidity and mortality in multiple surgical settings. To our knowledge, the effect of MetS on 30-day outcomes following elective lumbar spinal fusion has not been well studied. METHODS: An analysis of ACS-NSQIP data was performed between 2006 and 2013. Patients undergoing elective posterior lumbar fusion were identified. Emergency procedures, infections, tumor cases, and revision surgeries were excluded. Patients were defined as having MetS if they had a history of hypertension requiring medication, diabetes, and a body mass index (BMI) ≥30 kg/m. RESULTS: One thousand five hundred ninety (10.2%) patients with MetS were identified. A mild increase in major (P = 0.040) and minor complications (P = 0.003) in patients with MetS was noted. MetS was associated with increased rates of pulmonary complications (1.9% compared with 1.0%; P = 0.001), sepsis (1.7% compared with 0.9%; P = 0.005), and acute post-op renal failure (0.4% compared with 0%; P < 0.001). Multivariate analysis confirmed MetS to be an independent predictor of pulmonary complications [odds ratio (OR) 1.51; 95% confidence interval (95% CI 1.00-2.27); P = 0.048], sepsis (OR 1.56; 95% CI 1.01-2.42; P = 0.039), and acute postoperative renal failure (OR 6.95; 95% CI 2.23-21.67; P = 0.001). MetS status was associated with a mild increase in total hospital length of stay (4.38 compared with 3.81 days; P < 0.001). CONCLUSION: While MetS is a predictor of postoperative acute renal failure, it only slightly increases the risk of overall complications and is not associated with increased rates of 30-day reoperations or readmissions following elective lumbar fusion. LEVEL OF EVIDENCE: 3.
引用
- Chung AS, Campbell D, Waldrop R, et al. Metabolic Syndrome and 30-Day Outcomes in Elective Lumbar Spinal Fusion. Spine (Phila Pa 1976). 2018. PMID: 28858182. doi:10.1097/BRS.0000000000002397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。